Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB).
Sassaki LY, Magro DO, Saad-Hossne R, Baima JP, Flores C, Correia LM, Celani LMS, De Abreu Ferrari ML, Zacharias P, Feitosa MR, Dos Santos CHM, De Freitas Lins Neto MA, Quaresma AB, De Lima Junior SF, De Vasconcelos GBS, Cassol OS, Dos Santos Pinto A, Kurachi G, Goncalves Filho FA, Gasparini RG, Furlan TK, Catapani WR, Coy CSR, De Souza Menegassi V, Colombo MM, Fróes RSB, Teixeira FV, Moraes AC, Santana GO, Parente JML, Vilela EG, Queiroz NSF, Kotze PG; GEDIIB (Brazilian Study Group of IBD). Sassaki LY, et al. Among authors: vilela eg. BMC Gastroenterol. 2022 May 29;22(1):268. doi: 10.1186/s12876-022-02341-7. BMC Gastroenterol. 2022. PMID: 35644668 Free PMC article.
Ulcerative colitis - treatment with biologicals.
Teixeira FV, Vilela EG, Damião AOMC, Vieira A, Albuquerque IC, Parente JML, Chebli JMF, Ambrogini Junior O, Hossne RS, Miszputen SJ. Teixeira FV, et al. Among authors: vilela eg. Rev Assoc Med Bras (1992). 2019 May 2;65(4):547-553. doi: 10.1590/1806-9282.65.4.547. Rev Assoc Med Bras (1992). 2019. PMID: 31066808 Free article.
INFLAMMATORY BOWEL DISEASE CARE IN BRAZIL: HOW IT IS PERFORMED, OBSTACLES AND DEMANDS FROM THE PHYSICIANS' PERSPECTIVE.
Vilela EG, Rocha HC, Moraes AC, Santana GO, Parente JM, Sassaki LY, Miszputen SJ, Quaresma AB, Clara APHS, Jesus ACS, Pinto ADS, Silva BLPSD, Silva BCD, Freire CCF, Santos CHMD, Brito C, Teixeira EFL, Miranda EF, Zabot GP, Duarte JL, Ludvig JC, Campos-Lobato LF, Cassol OS, Souza MM, Almeida NP, Parra RS, Lima JÚnior SF, Saad-Hossne R. Vilela EG, et al. Arq Gastroenterol. 2020 Oct-Dec;57(4):416-427. doi: 10.1590/S0004-2803.202000000-77. Arq Gastroenterol. 2020. PMID: 33331475 Free article.
Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn's disease: a real-world multicenter Brazilian study.
Parra RS, Chebli JMF, Queiroz NSF, Damião AOMC, de Azevedo MFC, Chebli LA, Bertges ER, Alves Junior AJT, Ambrogini Junior O, da Silva BLPS, Lubini M, Bafutto M, Flores C, Vilela EG, Boratto SF, Gasparetti Junior NLT, Steinwurz F, Carvalho NS, Féres O, da Rocha JJR. Parra RS, et al. Among authors: vilela eg. BMC Gastroenterol. 2022 Apr 21;22(1):199. doi: 10.1186/s12876-022-02280-3. BMC Gastroenterol. 2022. PMID: 35448949 Free PMC article.
SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF CROHN'S DISEASE IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).
Imbrizi M, Baima JP, Azevedo MFC, Andrade AR, Queiroz NSF, Chebli JMF, Chebli LA, Argollo MC, Sassaki LY, Parra RS, Quaresma AB, Vieira A, Damião AOMC, Moraes ACDS, Flores C, Zaltman C, Vilela EG, Morsoletto EM, Gonçalves Filho FA, Penna FGCE, Santana GO, Zabot GP, Parente JML, Costa MHM, Zerôncio MA, Machado MB, Cassol OS, Kotze PG, Fróes RSB, Miszputen SJ, Ambrogini Junior O, Saad-Hossne R, Coy CSR. Imbrizi M, et al. Among authors: vilela eg. Arq Gastroenterol. 2023 Mar 24;59(suppl 1):20-50. doi: 10.1590/S0004-2803.2022005S1-02. eCollection 2023. Arq Gastroenterol. 2023. PMID: 36995888 Free article.
SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF ULCERATIVE COLITIS IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).
Baima JP, Imbrizi M, Andrade AR, Chebli LA, Argollo MC, Queiroz NSF, Azevedo MFC, Vieira A, Costa MHM, Fróes RSB, Penna FGCE, Quaresma AB, Damião AOMC, Moraes ACDS, Santos CHMD, Flores C, Zaltman C, Vilela EG, Morsoletto E, Gonçalves Filho FA, Santana GO, Zabot GP, Parente JML, Sassaki LY, Zerôncio MA, Machado MB, Cassol OS, Kotze PG, Parra RS, Miszputen SJ, Coy CSR, Ambrogini Junior O, Chebli JMF, Saad-Hossne R. Baima JP, et al. Among authors: vilela eg. Arq Gastroenterol. 2023 Mar 24;59(suppl 1):51-84. doi: 10.1590/S0004-2803.2022005S1-03. eCollection 2023. Arq Gastroenterol. 2023. PMID: 36995889 Free article.
P052 National Registration of Patients With Inflammatory Bowel Disease in Brazil on Behalf of GEDIIB.
Faria M, Sassaki L, Andrade A, Kaiser Junior R, Parra R, Herrerias G, Quaresma A, Santana G, Santos C, Bafutto M, Miszputen S, Barros J, Nascimento C, Scanferla K, Moraes A, Parente J, Vilela E, Saad-Hossne R, Fróes R. Faria M, et al. Am J Gastroenterol. 2021 Dec 1;116(Suppl 1):S13-S14. doi: 10.14309/01.ajg.0000798808.75513.51. Am J Gastroenterol. 2021. PMID: 37461970
Vedolizumab in Mild-to-Moderate Crohn's Disease Patients Naïve to Biological Therapy: A Multicentric Observational Study.
Dotti AZ, Magro DO, Vilela EG, Chebli JMF, Chebli LA, Steinwurz F, Argollo M, Carvalho NS, Parente JML, Lima MM, Parra RS, Perin RL, Flores C, Morsoletto EM, da Costa Ferreira S, Ludvig JC, Kaiser Junior RL, Faria MAG, Nicollelli GM, Andrade AR, Queiroz NSF, Kotze PG. Dotti AZ, et al. Among authors: vilela eg. Crohns Colitis 360. 2023 Sep 22;5(4):otad053. doi: 10.1093/crocol/otad053. eCollection 2023 Oct. Crohns Colitis 360. 2023. PMID: 37859629 Free PMC article.
53 results